Cannabotech Ltd. engages in research and development, production, and sale of medical and paramedical products based on medical cannabis and mushrooms extracts. It operates through the following segments: Development and sale of Preventive Medicine Products Based on CBD and Medicinal Mushrooms for the British Market; Development of Integrative Oncology Products Based on Medical Cannabis and Nutritional Supplements Based on Mushrooms; and Development of Botanical Medicines. The company was founded by Elchanan Shaked, Dobroslav Melamed, Yoav Rothler, and Sarel Chen-Tov on January 2, 2019 and is headquartered in Hertsliya, Israel.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company